Imidazo[1,2-a]pyridin-3-yl(phenyl)methanone, 97.0%, 5g

4-[(2,4-Dimethylphenyl)sulfanyl]aniline hydrochloride, 95%, 250mg

(1-(4-Bromophenyl)cyclobutyl)methanol, 95.0%, 250mg

Oxalato de disodio, mínimo 99,5 %, pa, ACS, 500 g, envase de plástico.

5-cyclobutyl-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

2-Chloro-N-methylaniline>98.0%(GC)(T)1g

4-Pyridin-2-ylbenzoic acid, 97.0%, 5g

Sodium 2,4,5-trichlorophenolate, 97%, 5g

Solución de eosina Y, 500 ml.

2-Fluoro-6-(tetrahydro-2H-pyran-4-yloxy)aniline, 95.0%, 1g

tert-Butyl 6-formyl-2-azaspiro[3.3]heptane-2-carboxylate, 95.0%, 5g

6-Chloro-4-(trifluoromethyl)nicotinonitrile, 95.0%, 10g

1-{2-[(3,5-dimethylphenyl)amino]-2-oxoethyl}piperidine-4-carboxylic acid, 95.0%, 1g